Các tác động đặc hiệu của đồng phân CLA lên biểu hiện gen trong mô mỡ của người phụ thuộc vào đa hình PPARγ2 P12A: một nghiên cứu ngẫu nhiên, mù đôi, đối chứng với thiết kế chéo

Park Y, Albright KJ, Liu W: Effect of conjugated linoleic acid on body composition in mice. Lipids. 1997, 32: 853-858. 10.1007/s11745-997-0109-x Ryder JW, Portocarrero CP, Song XM, Cui L, Yu M, Combatsiaris T, Galuska D, Bauman DE, Barbano DM, Charron MJ: Isomer-Specific Antidiabetic Properties of Conjugated Linoleic Acid: Improved Glucose Tolerance, Skeletal Muscle Insulin Action, and UCP-2 Gene Expression. Diabetes. 2001, 50: 1149-1157. 10.2337/diabetes.50.5.1149 Evans ME, Brown JM, McIntosh MK: Isomer-specific effects of conjugated linoleic acid (CLA) on adiposity and lipid metabolism. J Nutr Biochem. 2002, 13: 508-516. 10.1016/S0955-2863(02)00211-5 Whigham LD, Watras AC, Schoeller DA: Efficacy of conjugated linoleic acid for reducing fat mass: a meta-analysis in humans. Am J Clin Nutr. 2007, 85: 1203-1211. Fajas L, Auboeuf D, Raspe E, Schoonjans K, Lefebvre A-M, Saladin R, Najib J, Laville M, Fruchart J-C, Deeb S: The Organization, Promoter Analysis, and Expression of the Human PPARgamma Gene. J Biol Chem. 1997, 272: 18779-18789. 10.1074/jbc.272.30.18779 Tonjes A, Scholz M, Loeffler M, Stumvoll M: Association of Pro12Ala Polymorphism in Peroxisome Proliferator-Activated Receptor {gamma} With Pre-Diabetic Phenotypes: Meta-analysis of 57 studies on nondiabetic individuals. Diabetes Care. 2006, 29: 2489-2497. 10.2337/dc06-0513 Helwig U, Rubin D, Kiosz J, Schreiber S, Folsch UR, Nothnagel M, Doring F, Schrezenmeir J: The minor allele of the PPARgamma2 pro12Ala polymorphism is associated with lower postprandial TAG and insulin levels in non-obese healthy men. Br J Nutr. 2007, 97: 847-854. 10.1017/S0007114507665179 Ylonen SK, Salminen I, Lyssenko V, Virtanen SM, Groop L, Aro A, Saloranta C: The Pro12Ala polymorphism of the PPAR-[gamma]2 gene affects associations of fish intake and marine n-3 fatty acids with glucose metabolism. Eur J Clin Nutr. 2007, 62: 1432-1439. 10.1038/sj.ejcn.1602882 Houseknecht KL, Heuvel Vanden JP, Moya-Camarena SY, Portocarrero CP, Peck LW, Nickel KP, Belury MA: Dietary conjugated linoleic acid normalizes impaired glucose tolerance in the Zucker diabetic fatty fa/fa rat. Biochem Biophys Res Commun. 1998, 244: 678-682. 10.1006/bbrc.1998.8303 Nazare JA, de la Perriere AB, Bonnet F, Desage M, Peyrat J, Maitrepierre C, Louche-Pelissier C, Bruzeau J, Goudable J, Lassel T: Daily intake of conjugated linoleic acid-enriched yoghurts: effects on energy metabolism and adipose tissue gene expression in healthy subjects. Br J Nutr. 2007, 97: 273-280. 10.1017/S0007114507191911 Helwig U, Rubin D, Kiosz J, Bitter W, Schreiber S, Doring F, Folsch UR, Schrezenmeir J: The effects of retinol on postprandial parameters in men with different FABP2 promoter haplotypes. Horm Metab Res. 2007, 39: 237-243. 10.1055/s-2007-972578 Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP: Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostat. 2003, 4: 249-264. 10.1093/biostatistics/4.2.249. 10.1093/biostatistics/4.2.249 Westfall PH, Young SS: P-value adjustments for multiple tests in multivariate binomial models. J Am Stat Assoc. 1989, 84: 780-786. 10.2307/2289666. 10.2307/2289666 Wenzel JJ, Piehler A, Kaminski WE: ABC A-subclass proteins: gatekeepers of cellular phospho- and sphingolipid transport. Front Biosci. 2007, 12: 3177-3193. 10.2741/2305 Piehler A, Kaminski WE, Wenzel JJ, Langmann T, Schmitz G: Molecular structure of a novel cholesterol-responsive A subclass ABC transporter, ABCA9. Biochem Biophys Res Commun. 2002, 295: 408-416. 10.1016/S0006-291X(02)00659-9 Yu-Poth S, Yin D, Zhao G, Kris-Etherton PM, Etherton TD: Conjugated Linoleic Acid Upregulates LDL Receptor Gene Expression in HepG2 Cells. J Nutr. 2004, 134: 68-71. Degrace P, Demizieux L, Gresti J, Chardigny J-M, Sébédio J-L, Clouet P: Association of liver steatosis with lipid oversecretion and hypotriglyceridaemia in C57BL/6j mice fed trans-10, cis-12-linoleic acid. FEBS Lett. 2003, 546: 335-339. 10.1016/S0014-5793(03)00610-0 Granlund L, Pedersen JI, Nebb HI: Impaired lipid accumulation by trans10, cis12 CLA during adipocyte differentiation is dependent on timing and length of treatment. Biochim Biophy Acta. 2005, 1687: 11-22. Degrace P, Moindrot B, Mohamed I, Gresti J, Du Z-Y, Chardigny J-M, Sebedio J-L, Clouet P: Upregulation of liver VLDL receptor and FAT/CD36 expression in LDLR-/- apoB100/100 mice fed trans-10, cis-12 conjugated linoleic acid. J Lipid Res. 2006, 47: 2647-2655. 10.1194/jlr.M600140-JLR200 Chen M, Yang YK, Loux TJ, Georgeson KE, Harmon CM: The role of hyperglycemia in FAT/CD36 expression and function. Pediatr Surg Int. 2006, 22: 647-654. 10.1007/s00383-006-1704-x Yang YK, Chen M, Clements RH, Abrams GA, Aprahamian CJ, Harmon CM: Human mesenteric adipose tissue plays unique role versus subcutaneous and omental fat in obesity related diabetes. Cell Physiol Biochem. 2008, 22: 531-538. 10.1159/000185527 Deeb SS, Fajas L, Nemoto M, Pihlajamaki J, Mykkanen L, Kuusisto J, Laakso M, Fujimoto W, Auwerx J: A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet. 1998, 20: 284-287. 10.1038/3099 Deng T, Shan S, Li P-P, Shen Z-F, Lu X-P, Cheng J, Ning Z-Q: Peroxisome Proliferator-Activated Receptor-{gamma} Transcriptionally Up-Regulates Hormone-Sensitive Lipase via the Involvement of Specificity Protein-1. Endocrinology. 2006, 147: 875-884. 10.1210/en.2005-0623 Lasa A, Churruca I, Simon E, Fernandez-Quintela A, Rodriguez VM, Portillo MP: Trans-10, cis-12-conjugated linoleic acid does not increase body fat loss induced by energy restriction. Br J Nutr. 2008, 100: 1245-1250. 10.1017/S000711450800305X Stanton LW, Ponte PA, Coleman RT, Snyder MA: Expression of CA III in rodent models of obesity. Mol Endocrinol. 1991, 5: 860-866. 10.1210/mend-5-6-860 Alver A, Uçar F, Keha EE, Kalay E, Ovali E: Effects of Leptin and Insulin on CA III Expression in Rat Adipose Tissue. J Enzyme Inhib Med Chem. 2004, 19: 279-281. 10.1080/14756360410001720445 Wauters M, Considine RV, Van Gaal LF: Human leptin: from an adipocyte hormone to an endocrine mediator. Eur J Endocrinol. 2000, 143: 293-311. 10.1530/eje.0.1430293 Claycombe KJ, Jones BH, Standridge MK, Guo Y, Chun JT, Taylor JW, Moustaid-Moussa N: Insulin increases fatty acid synthase gene transcription in human adipocytes. Am J Physiol. 1998, 274: R1253-1259. Berndt J, Kovacs P, Ruschke K, Kloting N, Fasshauer M, Schon MR, Korner A, Stumvoll M, Bluher M: Fatty acid synthase gene expression in human adipose tissue: association with obesity and type 2 diabetes. Diabetologia. 2007, 50: 1472-1480. 10.1007/s00125-007-0689-x Flowers MT, Ntambi JM: Stearoyl-CoA desaturase and its relation to high-carbohydrate diets and obesity. Biochim Biophys Acta. 2009, 1791: 85-91. Kim Y-C, Ntambi JM: Regulation of Stearoyl-CoA Desaturase Genes: Role in Cellular Metabolism and Preadipocyte Differentiation. Biochem Biophys Res Commun. 1999, 266: 1-4. 10.1006/bbrc.1999.1704 Brown JM, Boysen MS, Jensen SS, Morrison RF, Storkson J, Lea-Currie R, Pariza M, Mandrup S, McIntosh MK: Isomer-specific regulation of metabolism and PPAR{gamma} signaling by CLA in human preadipocytes. J Lipid Res. 2003, 44: 1287-1300. 10.1194/jlr.M300001-JLR200 Sjogren P, Sierra-Johnson J, Gertow K, Rosell M, Vessby B, de Faire U, Hamsten A, Hellenius ML, Fisher RM: Fatty acid desaturases in human adipose tissue: relationships between gene expression, desaturation indexes and insulin resistance. Diabetologia. 2008, 51: 328-335. 10.1007/s00125-007-0876-9 Yao-Borengasser A, Rassouli N, Varma V, Bodles AM, Rasouli N, Unal R, Phanavanh B, Ranganathan G, McGehee RE, Kern PA: Stearoyl-Coenzyme A Desaturase 1 Gene Expression Increases after Pioglitazone Treatment and Is Associated with Peroxisomal Proliferator-Activated Receptor-{gamma} Responsiveness. J Clin Endocrinol Metab. 2008, 93: 4431-4439. 10.1210/jc.2008-0782 Schmitz-Peiffer C, Craig DL, Biden TJ: Ceramide Generation Is Sufficient to Account for the Inhibition of the Insulin-stimulated PKB Pathway in C2C12 Skeletal Muscle Cells Pretreated with Palmitate. J Biol Chem. 1999, 274: 24202-24210. 10.1074/jbc.274.34.24202 Mangravite LM, Dawson K, Davis RR, Gregg JP, Krauss RM: Fatty acid desaturase regulation in adipose tissue by dietary composition is independent of weight loss and is correlated with the plasma triacylglycerol response. Am J Clin Nutr. 2007, 86: 759-767. Steffen LM, Vessby B, Jacobs DR, Steinberger J, Moran A, Hong CP, Sinaiko AR: Serum phospholipid and cholesteryl ester fatty acids and estimated desaturase activities are related to overweight and cardiovascular risk factors in adolescents. Int J Obes. 2008, 32: 1297-1304. 10.1038/ijo.2008.89. 10.1038/ijo.2008.89 Chung S, Brown JM, Provo JN, Hopkins R, McIntosh MK: Conjugated Linoleic Acid Promotes Human Adipocyte Insulin Resistance through NF{kappa}B-dependent Cytokine Production. J Biol Chem. 2005, 280: 38445-38456. 10.1074/jbc.M508159200 Bays H, Mandarino L, DeFronzo RA: Role of the Adipocyte, Free Fatty Acids, and Ectopic Fat in Pathogenesis of Type 2 Diabetes Mellitus: Peroxisomal Proliferator-Activated Receptor Agonists Provide a Rational Therapeutic Approach. J Clin Endocrinol Metab. 2004, 89: 463-478. 10.1210/jc.2003-030723 Whigham LD, Watras AC, Schoeller DA: Efficacy of conjugated linoleic acid for reducing fat mass: a meta-analysis in humans. Am J Clin Nutr. 2007, 85: 1203-1211. Thrush AB, Chabowski A, Heigenhauser GJ, McBride BW, Or-Rashid M, Dyck DJ: Conjugated linoleic acid increases skeletal muscle ceramide content and decreases insulin sensitivity in overweight, non-diabetic humans. Appl Physiol Nutr Metab. 2007, 32: 372-382. 10.1139/H06-116 Riserus U, Vessby B, Arnlov J, Basu S: Effects of cis-9, trans-11 conjugated linoleic acid supplementation on insulin sensitivity, lipid peroxidation, and proinflammatory markers in obese men. Am J Clin Nutr. 2004, 80: 279-283. Kennedy A, Chung S, LaPoint K, Fabiyi O, McIntosh MK: Trans-10, Cis-12 Conjugated Linoleic Acid Antagonizes Ligand-Dependent PPAR{gamma} Activity in Primary Cultures of Human Adipocytes. J Nutr. 2008, 138: 455-461. Miller JR, Siripurkpong P, Hawes J, Majdalawieh A, Ro H-S, McLeod RS: The trans-10, cis-12 isomer of conjugated linoleic acid decreases adiponectin assembly by PPAR{gamma}-dependent and PPAR{gamma}-independent mechanisms. J Lipid Res. 2008, 49: 550-562. 10.1194/jlr.M700275-JLR200 Nakamura YK, Omaye ST: Conjugated linoleic acid isomers' roles in the regulation of PPAR-[gamma] and NF-[kappa]B DNA binding and subsequent expression of antioxidant enzymes in human umbilical vein endothelial cells. Nutrition. 2009, 25: 800-811. 10.1016/j.nut.2009.01.003 Clement L, Poirier H, Niot I, Bocher V, Guerre-Millo M, Krief S, Staels B, Besnard P: Dietary trans-10, cis-12 conjugated linoleic acid induces hyperinsulinemia and fatty liver in the mouse. J Lipid Res. 2002, 43: 1400-1409. 10.1194/jlr.M20008-JLR200 Yang B, Hodgkinson AD, Oates PJ, Kwon HM, Millward BA, Demaine AG: Elevated Activity of Transcription Factor Nuclear Factor of Activated T-Cells 5 (NFAT5) and Diabetic Nephropathy. Diabetes. 2006, 55: 1450-1455. 10.2337/db05-1260 Shimizu H, Ohtani KI, Tsuchiya T, Sato N, Tanaka Y, Takahashi H, Uehara Y, Inukai T, Mori M: Aldose reductase mRNA expression is associated with rapid development of diabetic microangiopathy in Japanese Type 2 diabetic (T2DM) patients. Diabetes Nutr Metab. 2000, 13: 75-79. Mayr B, Montminy M: Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol. 2001, 2: 599-609. 10.1038/35085068 Bouchard L, Tchernof A, Deshaies Y, Marceau S, Lescelleur O, Biron S, Vohl MC: ZFP36: a Promising Candidate Gene for Obesity-Related Metabolic Complications Identified by Converging Genomics. Obesity Surgery. 2007, 17: 372-382. 10.1007/s11695-007-9067-5 Granlund L, Pedersen JI, Nebb HI: Impaired lipid accumulation by trans10, cis12 CLA during adipocyte differentiation is dependent on timing and length of treatment. Biochim Biophys Acta. 2005, 1687: 11-22. Zhou Y-T, Shimabukuro M, Koyama K, Lee Y, Wang M-Y, Trieu F, Newgard CB, Unger RH: Induction by leptin of uncoupling protein-2 and enzymes of fatty acid oxidation. Proc Natl Acad Sci USA. 1997, 94: 6386-6390. 10.1073/pnas.94.12.6386 Yamagishi S-i, Edelstein D, Du X-l, Kaneda Y, Guzman M, Brownlee M: Leptin Induces Mitochondrial Superoxide Production and Monocyte Chemoattractant Protein-1 Expression in Aortic Endothelial Cells by Increasing Fatty Acid Oxidation via Protein Kinase A. J Biol Chem. 2001, 276: 25096-25100. 10.1074/jbc.M007383200 Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF: Serum Immunoreactive-Leptin Concentrations in Normal-Weight and Obese Humans. N Engl J Med. 1996, 334: 292-295. 10.1056/NEJM199602013340503 Korda M, Kubant R, Patton S, Malinski T: Leptin-induced endothelial dysfunction in obesity. Am J Physiol Heart Circ Physiol. 2008, 295: H1514-1521. 10.1152/ajpheart.00479.2008 Singh P, Hoffmann M, Wolk R, Shamsuzzaman ASM, Somers VK: Leptin Induces C-Reactive Protein Expression in Vascular Endothelial Cells. Arterioscler Thromb Vasc Biol. 2007, 27: e302-307. 10.1161/ATVBAHA.107.148353 Prais Botelho A, Santos-Zago LF, Costa de Oliveira A: Conjugated linoleic acid supplementation modified the body composition and serum leptin levels in weaning rats. Arch Latinoam Nutr. 2008, 58: 156-163. Mousavinasab F, Tähtinen T, Jokelainen J, Koskela P, Vanhala M, Oikarinen J, Keinänen-Kiukaanniemi S, Laakso M: Common polymorphisms in the PPAR[gamma]2 and IRS-1 genes and their interaction influence serum adiponectin concentration in young Finnish men. Mol Genet Metab. 2005, 84: 344-348. 10.1016/j.ymgme.2004.11.008 Takata N, Awata T, Inukai K, Watanabe M, Ohkubo T, Kurihara S, Inaba M, Katayama S: Pro12Ala substitution in peroxisome proliferator-activated receptor[gamma]2 is associated with low adiponectin concentrations in young Japanese men. Metabolism. 2004, 53: 1548- 10.1016/j.metabol.2004.06.022 McFarlin BK, Strohacker KA, Kueht ML: Pomegranate seed oil consumption during a period of high-fat feeding reduces weight gain and reduces type 2 diabetes risk in CD-1 mice. Br J Nutr. 2009, 102: 54-59. 10.1017/S0007114508159001 Dogru T, Sonmez A, Tasci I, Bozoglu E, Yilmaz MI, Genc H, Erdem G, Gok M, Bingol N, Kilic S: Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance. Diabetes Res Clin Pract. 2007, 76: 24-29. 10.1016/j.diabres.2006.07.031 Pfutzner A, Marx N, Walcher D, Lobig M, Seidel D, Forst T: Impact of rosiglitazone on visfatin and adiponectin plasma concentrations in patients with type 2 diabetes and coronary artery disease. Clin Lab. 2008, 54: 237-241. Hammarstedt A, Pihlajamaki J, Rotter Sopasakis V, Gogg S, Jansson P-A, Laakso M, Smith U: Visfatin Is an Adipokine, But It Is Not Regulated by Thiazolidinediones. J Clin Endocrinol Metab. 2006, 91: 1181-1184. 10.1210/jc.2005-1395 Varma V, Yao-Borengasser A, Bodles AM, Rasouli N, Phanavanh B, Nolen GT, Kern EM, Nagarajan R, Spencer HJ, Lee M-J: Thrombospondin-1 Is an Adipokine Associated With Obesity, Adipose Inflammation, and Insulin Resistance. Diabetes. 2008, 57: 432-439. 10.2337/db07-0840 Huang H, Campbell SC, Bedford DF, Nelius T, Veliceasa D, Shroff EH, Henkin J, Schneider A, Bouck N, Volpert OV: Peroxisome Proliferator-Activated Receptor {gamma} Ligands Improve the Antitumor Efficacy of Thrombospondin Peptide ABT510. Mol Cancer Res. 2004, 2: 541-550. Kim EJ, Kang I-J, Cho HJ, Kim WK, Ha Y-L, Park JHY: Conjugated Linoleic Acid Downregulates Insulin-Like Growth Factor-I Receptor Levels in HT-29 Human Colon Cancer Cells. J Nutr. 2003, 133: 2675-2681. Hussain MA, Schmitz O, Mengel A, Keller A, Christiansen JS, Zapf J, Froesch ER: Insulin-like growth factor I stimulates lipid oxidation, reduces protein oxidation, and enhances insulin sensitivity in humans. J Clin Invest. 1993, 92: 2249-2256. 10.1172/JCI116828 Marin P, Kvist H, Lindstedt G, Sjostrom L, Bjorntorp P: Low concentrations of insulin-like growth factor-I in abdominal obesity. Int J Obes Relat Metab Disord. 1993, 17: 83-89. Rasmussen MH, Frystyk J, Andersen T, Breum L, Christiansen JS, Hilsted J: The impact of obesity, fat distribution, and energy restriction on insulin-like growth factor-1 (IGF-1), IGF-binding protein-3, insulin, and growth hormone. Metabolism. 1994, 43: 315-319. 10.1016/0026-0495(94)90099-X Moloney F, Toomey S, Noone E, Nugent A, Allan B, Loscher CE, Roche HM: Antidiabetic Effects of cis-9, trans-11-Conjugated Linoleic Acid May Be Mediated via Anti-Inflammatory Effects in White Adipose Tissue. Diabetes. 2007, 56: 574-582. 10.2337/db06-0384 Riserus U, Vessby B, Arnlov J, Basu S: Effects of cis-9, trans-11 conjugated linoleic acid supplementation on insulin sensitivity, lipid peroxidation, and proinflammatory markers in obese men. Am J Clin Nutr. 2004, 80: 279-283. Riserus U, Arner P, Brismar K, Vessby B: Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care. 2002, 25: 1516-1521. 10.2337/diacare.25.9.1516 Ribon V, Printen JA, Hoffman NG, Kay BK, Saltiel AR: A Novel, Multifunctional c-Cbl Binding Protein in Insulin Receptor Signaling in 3T3-L1 Adipocytes. Mol Cell Biol. 1998, 18: 872-879. Ribon V, Johnson JH, Camp HS, Saltiel AR: Thiazolidinediones and insulin resistance: Peroxisome proliferatoractivated receptor gamma activation stimulates expression of the CAP gene. Proc Natl Acad Sci USA. 1998, 95: 14751-14756. 10.1073/pnas.95.25.14751 Ueki K, Algenstaedt P, Mauvais-Jarvis F, Kahn CR: Positive and Negative Regulation of Phosphoinositide 3-Kinase-Dependent Signaling Pathways by Three Different Gene Products of the p85alpha Regulatory Subunit. Mol Cell Biol. 2000, 20: 8035-8046. 10.1128/MCB.20.21.8035-8046.2000 Shepherd PR, Withers DJ, Siddle K: Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling. Biochem J. 1998, 333: 471-490. Chou W-L, Chuang L-M, Chou C-C, Wang AHJ, Lawson JA, FitzGerald GA, Chang Z-F: Identification of a Novel Prostaglandin Reductase Reveals the Involvement of Prostaglandin E2 Catabolism in Regulation of Peroxisome Proliferator-activated Receptor {gamma} Activation. J Biol Chem. 2007, 282: 18162-18172. 10.1074/jbc.M702289200 Rega G, Kaun C, Weiss TW, Demyanets S, Zorn G, Kastl SP, Steiner S, Seidinger D, Kopp CW, Frey M: Inflammatory Cytokines Interleukin-6 and Oncostatin M Induce Plasminogen Activator Inhibitor-1 in Human Adipose Tissue. Circulation. 2005, 111: 1938-1945. 10.1161/01.CIR.0000161823.55935.BE Camirand A, Marie V, Rabelo R, Silva JE: Thiazolidinediones Stimulate Uncoupling Protein-2 Expression in Cell Lines Representing White and Brown Adipose Tissues and Skeletal Muscle. Endocrinology. 1998, 139: 428-431. 10.1210/en.139.1.428 Chevillotte E, Giralt M, Miroux B, Ricquier D, Villarroya F: Uncoupling Protein-2 Controls Adiponectin Gene Expression in Adipose Tissue Through the Modulation of Reactive Oxygen Species Production. Diabetes. 2007, 56: 1042-1050. 10.2337/db06-1300 Lantner F, Starlets D, Gore Y, Flaishon L, Yamit-Hezi A, Dikstein R, Leng L, Bucala R, Machluf Y, Oren M, Shachar I: CD74 induces TAp63 expression leading to B-cell survival. Blood. 2007, 110: 4303-4311. 10.1182/blood-2007-04-087486 Morris EJ, Michaud WA, Ji JY, Moon NS, Rocco JW, Dyson NJ: Functional identification of Api5 as a suppressor of E2F-dependent apoptosis in vivo. PLoS Genet. 2006, 2: e196- 10.1371/journal.pgen.0020196 Bhattacharya A, Banu J, Rahman M, Causey J, Fernandes G: Biological effects of conjugated linoleic acids in health and disease. J Nutr Biochem. 2006, 17: 789-810. 10.1016/j.jnutbio.2006.02.009 Murphy EF, Hooiveld GJ, Muller M, Calogero RA, Cashman KD: Conjugated Linoleic Acid Alters Global Gene Expression in Human Intestinal-Like Caco-2 Cells in an Isomer-Specific Manner. J Nutr. 2007, 137: 2359-2365. Yu S, Matsusue K, Kashireddy P, Cao W-Q, Yeldandi V, Yeldandi AV, Rao MS, Gonzalez FJ, Reddy JK: Adipocyte-specific Gene Expression and Adipogenic Steatosis in the Mouse Liver Due to Peroxisome Proliferator-activated Receptor gamma 1 (PPARgamma 1) Overexpression. J Biol Chem. 2003, 278: 498-505. 10.1074/jbc.M210062200 Tontonoz P, Nagy L, Alvarez JG, Thomazy VA, Evans RM: PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell. 1998, 93: 241-252. 10.1016/S0092-8674(00)81575-5 Way JM, Harrington WW, Brown KK, Gottschalk WK, Sundseth SS, Mansfield TA, Ramachandran RK, Willson TM, Kliewer SA: Comprehensive Messenger Ribonucleic Acid Profiling Reveals That Peroxisome Proliferator-Activated Receptor {{gamma}} Activation Has Coordinate Effects on Gene Expression in Multiple Insulin-Sensitive Tissues. Endocrinology. 2001, 142: 1269-1277. 10.1210/en.142.3.1269 Zhang L, Ge L, Tran T, Stenn K, Prouty SM: Isolation and characterization of the human stearoyl-CoA desaturase gene promoter: requirement of a conserved CCAAT cis-element. Biochem J. 2001, 357: 183-193. 10.1042/0264-6021:3570183 Jimenez MA, Akerblad P, Sigvardsson M, Rosen ED: Critical Role for Ebf1 and Ebf2 in the Adipogenic Transcriptional Cascade. Mol Cell Biol. 2007, 27: 743-757. 10.1128/MCB.01557-06 Iwaki M, Matsuda M, Maeda N, Funahashi T, Matsuzawa Y, Makishima M, Shimomura I: Induction of Adiponectin, a Fat-Derived Antidiabetic and Antiatherogenic Factor, by Nuclear Receptors. Diabetes. 2003, 52: 1655-1663. 10.2337/diabetes.52.7.1655 Riera-Guardia N, Rothenbacher D: The effect of thiazolidinediones on adiponectin serum level: a meta-analysis. Diabetes Obes Metab. 2008, 10: 367-375. 10.1111/j.1463-1326.2007.00755.x Hollenberg AN, Susulic VS, Madura JP, Zhang B, Moller DE, Tontonoz P, Sarraf P, Spiegelman BM, Lowell BB: Functional Antagonism between CCAAT/Enhancer Binding Protein-alpha and Peroxisome Proliferator-activated Receptor-gamma on the Leptin Promoter. J Biol Chem. 1997, 272: 5283-5290. 10.1074/jbc.272.8.5283 Qin X, Shen H, Liu M, Yang Q, Zheng S, Sabo M, D'Alessio DA, Tso P: GLP-1 reduces intestinal lymph flow, triglyceride absorption, and apolipoprotein production in rats. Am JPhysiol Gastrointest Liver Physiol. 2005, 288: 943-949. 10.1152/ajpgi.00303.2004. 10.1152/ajpgi.00303.2004 Armoni M, Kritz N, Harel C, Bar-Yoseph F, Chen H, Quon MJ, Karnieli E: Peroxisome Proliferator-activated Receptor-{gamma} represses GLUT4 promoter activity in primary adipocytes, and rosiglitazone alleviates this effect. J Biol Chem. 2003, 278: 30614-30623. 10.1074/jbc.M304654200 Standaert ML, Kanoh Y, Sajan MP, Bandyopadhyay G, Farese RV: Cbl, IRS-1, and IRS-2 Mediate Effects of Rosiglitazone on PI3K, PKC-{lambda}, and Glucose Transport in 3T3/L1 Adipocytes. Endocrinology. 2002, 143: 1705-1716. 10.1210/en.143.5.1705